Literature DB >> 26177523

Viral manipulation of the host immune response.

Allison Christiaansen1, Steven M Varga2, Juliet V Spencer3.   

Abstract

Viruses are obligate intracellular parasites that require a host for essential machinery to replicate and ultimately be transmitted to new susceptible hosts. At the same time, the immune system has evolved to protect the human body from invasion by viruses and other pathogens. To counter this, viruses have developed an arsenal of strategies to not only avoid immune detection but to actively manipulate host immune responses to create an environment more favorable for infection. Here, we describe recent advances uncovering novel mechanisms by which viruses skew host immune responses through modulation of cytokine and chemokine signaling networks, interference with antigen presentation and T cell responses, and preventing antibody production.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177523      PMCID: PMC4593765          DOI: 10.1016/j.coi.2015.06.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  55 in total

1.  The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.

Authors:  Saskia Nijmeijer; Rob Leurs; Martine J Smit; Henry F Vischer
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

2.  IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

Authors:  Sumanta Mukherjee; Dennis M Lindell; Aaron A Berlin; Susan B Morris; Thomas P Shanley; Marc B Hershenson; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

Review 3.  The role of IL-10 in regulating immunity to persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 4.  Chemokines in respiratory viral infections: focus on their diagnostic and therapeutic potential.

Authors:  Virginia Amanatidou; Apostolos Zaravinos; Stavros Apostolakis; Demetrios A Spandidos
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

Review 5.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

6.  EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.

Authors:  Bryan D Griffin; Anna M Gram; Arend Mulder; Daphne Van Leeuwen; Frans H J Claas; Fred Wang; Maaike E Ressing; Emmanuel Wiertz
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

7.  A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction.

Authors:  Martin L Moore; Michael H Chi; Cindy Luongo; Nicholas W Lukacs; Vasiliy V Polosukhin; Matthew M Huckabee; Dawn C Newcomb; Ursula J Buchholz; James E Crowe; Kasia Goleniewska; John V Williams; Peter L Collins; R Stokes Peebles
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.

Authors:  Julia Hesse; Stefanie Ameres; Katrin Besold; Steffi Krauter; Andreas Moosmann; Bodo Plachter
Journal:  J Gen Virol       Date:  2012-10-24       Impact factor: 3.891

9.  Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.

Authors:  Gavin M Mason; Emma Poole; J G Patrick Sissons; Mark R Wills; John H Sinclair
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

10.  Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response.

Authors:  Shirin Munir; Philippa Hillyer; Cyril Le Nouën; Ursula J Buchholz; Ronald L Rabin; Peter L Collins; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2011-04-21       Impact factor: 6.823

View more
  23 in total

Review 1.  Analytical ultracentrifuge: an ideal tool for characterization of non-coding RNAs.

Authors:  Maulik D Badmalia; M Quadir Siddiqui; Tyler Mrozowich; Darren L Gemmill; Trushar R Patel
Journal:  Eur Biophys J       Date:  2020-10-16       Impact factor: 1.733

2.  Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.

Authors:  Miklos Z Molnar; Vishnu S Potluri; Douglas E Schaubel; Meghan E Sise; Beatrice P Concepcion; Rachel C Forbes; Emily Blumberg; Roy D Bloom; David Shaffer; Raymond T Chung; Ian A Strohbehn; Nahel Elias; Ambreen Azhar; Mital Shah; Deirdre Sawinski; Laura A Binari; Manish Talwar; Vasanthi Balaraman; Anshul Bhalla; James D Eason; Behdad Besharatian; Jennifer Trofe-Clark; David S Goldberg; Peter P Reese
Journal:  Am J Transplant       Date:  2021-10-06       Impact factor: 8.086

Review 3.  Monocyte/Macrophage-Mediated Innate Immunity in HIV-1 Infection: From Early Response to Late Dysregulation and Links to Cardiovascular Diseases Onset.

Authors:  Eman Teer; Danzil E Joseph; Richard H Glashoff; M Faadiel Essop
Journal:  Virol Sin       Date:  2021-01-05       Impact factor: 4.327

4.  Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.

Authors:  Hengfei Shi; Ke Ren; Baojie Lv; Wei Zhang; Ying Zhao; Ren Xiang Tan; Erguang Li
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

5.  CMV immune evasion and manipulation of the immune system with aging.

Authors:  Sarah E Jackson; Anke Redeker; Ramon Arens; Debbie van Baarle; Sara P H van den Berg; Chris A Benedict; Luka Čičin-Šain; Ann B Hill; Mark R Wills
Journal:  Geroscience       Date:  2017-06-24       Impact factor: 7.713

6.  PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.

Authors:  Daniela D'Arcangelo; Francesco Facchiano; Giovanni Nassa; Andrea Stancato; Annalisa Antonini; Stefania Rossi; Cinzia Senatore; Martina Cordella; Claudio Tabolacci; Annamaria Salvati; Roberta Tarallo; Alessandro Weisz; Angelo M Facchiano; Antonio Facchiano
Journal:  Oncotarget       Date:  2016-11-22

Review 7.  Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.

Authors:  Man Wang; Fei Yu; Wei Wu; Yu Wang; Han Ding; Lili Qian
Journal:  Int J Biol Sci       Date:  2018-04-05       Impact factor: 6.580

8.  Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma.

Authors:  Xuan Wang; Zhiyong Xiong; Zhen Liu; Xing Huang; Xiaobing Jiang
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

9.  Impact of Influenza A Virus Shutoff Proteins on Host Immune Responses.

Authors:  Megan M Dunagan; Kala Hardy; Toru Takimoto
Journal:  Vaccines (Basel)       Date:  2021-06-10

10.  Naïve CD8 T cell IFNγ responses to a vacuolar antigen are regulated by an inflammasome-independent NLRP3 pathway and Toxoplasma gondii ROP5.

Authors:  Angel K Kongsomboonvech; Felipe Rodriguez; Anh L Diep; Brandon M Justice; Brayan E Castallanos; Ana Camejo; Debanjan Mukhopadhyay; Gregory A Taylor; Masahiro Yamamoto; Jeroen P J Saeij; Michael L Reese; Kirk D C Jensen
Journal:  PLoS Pathog       Date:  2020-08-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.